Your browser doesn't support javascript.
loading
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review.
Yang, Chen-Yi; Chen, Ying-Ren; Ou, Huang-Tz; Kuo, Shihchen.
  • Yang CY; Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, 1 University Road, Tainan, Taiwan.
  • Chen YR; Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, 1 University Road, Tainan, Taiwan.
  • Ou HT; Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, 1 University Road, Tainan, Taiwan. huangtz@mail.ncku.edu.tw.
  • Kuo S; Department of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan. huangtz@mail.ncku.edu.tw.
Cardiovasc Diabetol ; 20(1): 21, 2021 01 19.
Article en En | MEDLINE | ID: mdl-33468131

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Costos de los Medicamentos / Diabetes Mellitus Tipo 2 / Incretinas / Hipoglucemiantes / Insulina Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Costos de los Medicamentos / Diabetes Mellitus Tipo 2 / Incretinas / Hipoglucemiantes / Insulina Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article